McKesson Corporation (MCK)
Bid | 672.43 |
Market Cap | 88.7B |
Revenue (ttm) | 344.58B |
Net Income (ttm) | 2.83B |
EPS (ttm) | 21.77 |
PE Ratio (ttm) | 32.51 |
Forward PE | 19.17 |
Analyst | Buy |
Ask | 713 |
Volume | 640,920 |
Avg. Volume (20D) | 1,004,180 |
Open | 712.46 |
Previous Close | 706.77 |
Day's Range | 703.87 - 716.40 |
52-Week Range | 464.42 - 728.32 |
Beta | 0.49 |
About MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management,...
Analyst Forecast
According to 14 analyst ratings, the average rating for MCK stock is "Buy." The 12-month stock price forecast is $675, which is a decrease of -4.63% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

1 week ago · benzinga.com
McKesson Shares Rise Nearly 1% After Key SignalMCK moves higher through the session after Alert

2 weeks ago · businesswire.com
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community OncologyIRVING, Texas--(BUSINESS WIRE)--McKesson launched an initiative addressing the clinical challenges and administrative burden practices face in the era of biomarker-directed care.